Molecular imaging of the kinetics of vascular endothelial growth factor gene expression in ischemic myocardium

Joseph C. Wu, Ian Y. Chen, Yanling Wang, Jeffrey R. Tseng, Ankush Chhabra, Mahdi Salek, Jung Joon Min, Michael C. Fishbein, Ronald Crystal, Sanjiv S. Gambhir

Research output: Contribution to journalArticle

88 Citations (Scopus)

Abstract

Background-Angiogenic gene therapy is a promising treatment paradigm for patients with ischemic heart disease. In this study, we used micro-positron emission tomography (microPET) to monitor the transgene expression, function, and effects in a whole-body system. Methods and Results-Adenovirus with cytomegalovirus promoter driving an angiogenic gene (vascular endothelial growth factor [VEGF]) linked to a PET reporter gene (herpes simplex virus type 1 mutant thymidine kinase; Ad-CMV-VEGF121-CMV-HSV1-sr39tk) was used to transfect rat embryonic cardiomyoblasts in vitro. Expression of both genes correlated strongly (r=0.98; P<0.001). Afterward, rats underwent ligation of the left anterior descending artery followed by injection of 1×10 10 pfu of Ad-CMV-VEGF121-CMV-HSV1-sr39tk (study; n=35) or Ad-null (control; n=15) at the peri-infarct region. Noninvasive microPET imaging was used to assess the uptake of 9-(4-[18F]- fluorohydroxymethylbutyl)guanine ([18F]-FHBG) PET reporter probe by cells expressing the HSV1-sr39tk PET reporter gene. Cardiac transgene expression peaked at day 1 and declined over the next 2 weeks. Repeat adenoviral injections at day 60 yielded no detectable signal. The in vivo reporter gene expression (% injected dose/g of [18F]-FHBG) correlated well with ex vivo gamma counting (r=0.92), myocardial tissue HSV1-sr39TK enzyme activity (r=0.95), and myocardial tissue VEGF level (r=0.94; P<0.001 for all). The VEGF121 isoform induced significant increases in capillaries and small blood vessels. However, the level of neovasculature did not translate into significant improvements in functional parameters such as myocardial contractility by echocardiography, perfusion by nitrogen-13 ammonia imaging, and metabolism by [18F]-fluorodeoxyglucose imaging. Conclusions-Taken together, these findings establish the feasibility of molecular imaging for monitoring angiogenic gene expression with a PET reporter gene and probe noninvasively, quantitatively, and repetitively. The principles demonstrated here can be used to evaluate other therapeutic genes of interest in animal models before future clinical trials are initiated.

Original languageEnglish
Pages (from-to)685-691
Number of pages7
JournalCirculation
Volume110
Issue number6
DOIs
Publication statusPublished - 10 Aug 2004
Externally publishedYes

Fingerprint

Molecular Imaging
Reporter Genes
Vascular Endothelial Growth Factor A
Myocardium
Gene Expression
Transgenes
Positron-Emission Tomography
Injections
Thymidine Kinase
Fluorodeoxyglucose F18
Guanine
Human Herpesvirus 1
Gene Expression Profiling
Cytomegalovirus
Ammonia
Adenoviridae
Genetic Therapy
Genes
Myocardial Ischemia
Ligation

Keywords

  • Angiogenesis
  • Gene therapy
  • Imaging
  • Myocardium
  • Nuclear medicine

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this

Wu, J. C., Chen, I. Y., Wang, Y., Tseng, J. R., Chhabra, A., Salek, M., ... Gambhir, S. S. (2004). Molecular imaging of the kinetics of vascular endothelial growth factor gene expression in ischemic myocardium. Circulation, 110(6), 685-691. https://doi.org/10.1161/01.CIR.0000138153.02213.22

Molecular imaging of the kinetics of vascular endothelial growth factor gene expression in ischemic myocardium. / Wu, Joseph C.; Chen, Ian Y.; Wang, Yanling; Tseng, Jeffrey R.; Chhabra, Ankush; Salek, Mahdi; Min, Jung Joon; Fishbein, Michael C.; Crystal, Ronald; Gambhir, Sanjiv S.

In: Circulation, Vol. 110, No. 6, 10.08.2004, p. 685-691.

Research output: Contribution to journalArticle

Wu, JC, Chen, IY, Wang, Y, Tseng, JR, Chhabra, A, Salek, M, Min, JJ, Fishbein, MC, Crystal, R & Gambhir, SS 2004, 'Molecular imaging of the kinetics of vascular endothelial growth factor gene expression in ischemic myocardium', Circulation, vol. 110, no. 6, pp. 685-691. https://doi.org/10.1161/01.CIR.0000138153.02213.22
Wu, Joseph C. ; Chen, Ian Y. ; Wang, Yanling ; Tseng, Jeffrey R. ; Chhabra, Ankush ; Salek, Mahdi ; Min, Jung Joon ; Fishbein, Michael C. ; Crystal, Ronald ; Gambhir, Sanjiv S. / Molecular imaging of the kinetics of vascular endothelial growth factor gene expression in ischemic myocardium. In: Circulation. 2004 ; Vol. 110, No. 6. pp. 685-691.
@article{8549f3e6dd654cbca55b99be12018fff,
title = "Molecular imaging of the kinetics of vascular endothelial growth factor gene expression in ischemic myocardium",
abstract = "Background-Angiogenic gene therapy is a promising treatment paradigm for patients with ischemic heart disease. In this study, we used micro-positron emission tomography (microPET) to monitor the transgene expression, function, and effects in a whole-body system. Methods and Results-Adenovirus with cytomegalovirus promoter driving an angiogenic gene (vascular endothelial growth factor [VEGF]) linked to a PET reporter gene (herpes simplex virus type 1 mutant thymidine kinase; Ad-CMV-VEGF121-CMV-HSV1-sr39tk) was used to transfect rat embryonic cardiomyoblasts in vitro. Expression of both genes correlated strongly (r=0.98; P<0.001). Afterward, rats underwent ligation of the left anterior descending artery followed by injection of 1×10 10 pfu of Ad-CMV-VEGF121-CMV-HSV1-sr39tk (study; n=35) or Ad-null (control; n=15) at the peri-infarct region. Noninvasive microPET imaging was used to assess the uptake of 9-(4-[18F]- fluorohydroxymethylbutyl)guanine ([18F]-FHBG) PET reporter probe by cells expressing the HSV1-sr39tk PET reporter gene. Cardiac transgene expression peaked at day 1 and declined over the next 2 weeks. Repeat adenoviral injections at day 60 yielded no detectable signal. The in vivo reporter gene expression ({\%} injected dose/g of [18F]-FHBG) correlated well with ex vivo gamma counting (r=0.92), myocardial tissue HSV1-sr39TK enzyme activity (r=0.95), and myocardial tissue VEGF level (r=0.94; P<0.001 for all). The VEGF121 isoform induced significant increases in capillaries and small blood vessels. However, the level of neovasculature did not translate into significant improvements in functional parameters such as myocardial contractility by echocardiography, perfusion by nitrogen-13 ammonia imaging, and metabolism by [18F]-fluorodeoxyglucose imaging. Conclusions-Taken together, these findings establish the feasibility of molecular imaging for monitoring angiogenic gene expression with a PET reporter gene and probe noninvasively, quantitatively, and repetitively. The principles demonstrated here can be used to evaluate other therapeutic genes of interest in animal models before future clinical trials are initiated.",
keywords = "Angiogenesis, Gene therapy, Imaging, Myocardium, Nuclear medicine",
author = "Wu, {Joseph C.} and Chen, {Ian Y.} and Yanling Wang and Tseng, {Jeffrey R.} and Ankush Chhabra and Mahdi Salek and Min, {Jung Joon} and Fishbein, {Michael C.} and Ronald Crystal and Gambhir, {Sanjiv S.}",
year = "2004",
month = "8",
day = "10",
doi = "10.1161/01.CIR.0000138153.02213.22",
language = "English",
volume = "110",
pages = "685--691",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Molecular imaging of the kinetics of vascular endothelial growth factor gene expression in ischemic myocardium

AU - Wu, Joseph C.

AU - Chen, Ian Y.

AU - Wang, Yanling

AU - Tseng, Jeffrey R.

AU - Chhabra, Ankush

AU - Salek, Mahdi

AU - Min, Jung Joon

AU - Fishbein, Michael C.

AU - Crystal, Ronald

AU - Gambhir, Sanjiv S.

PY - 2004/8/10

Y1 - 2004/8/10

N2 - Background-Angiogenic gene therapy is a promising treatment paradigm for patients with ischemic heart disease. In this study, we used micro-positron emission tomography (microPET) to monitor the transgene expression, function, and effects in a whole-body system. Methods and Results-Adenovirus with cytomegalovirus promoter driving an angiogenic gene (vascular endothelial growth factor [VEGF]) linked to a PET reporter gene (herpes simplex virus type 1 mutant thymidine kinase; Ad-CMV-VEGF121-CMV-HSV1-sr39tk) was used to transfect rat embryonic cardiomyoblasts in vitro. Expression of both genes correlated strongly (r=0.98; P<0.001). Afterward, rats underwent ligation of the left anterior descending artery followed by injection of 1×10 10 pfu of Ad-CMV-VEGF121-CMV-HSV1-sr39tk (study; n=35) or Ad-null (control; n=15) at the peri-infarct region. Noninvasive microPET imaging was used to assess the uptake of 9-(4-[18F]- fluorohydroxymethylbutyl)guanine ([18F]-FHBG) PET reporter probe by cells expressing the HSV1-sr39tk PET reporter gene. Cardiac transgene expression peaked at day 1 and declined over the next 2 weeks. Repeat adenoviral injections at day 60 yielded no detectable signal. The in vivo reporter gene expression (% injected dose/g of [18F]-FHBG) correlated well with ex vivo gamma counting (r=0.92), myocardial tissue HSV1-sr39TK enzyme activity (r=0.95), and myocardial tissue VEGF level (r=0.94; P<0.001 for all). The VEGF121 isoform induced significant increases in capillaries and small blood vessels. However, the level of neovasculature did not translate into significant improvements in functional parameters such as myocardial contractility by echocardiography, perfusion by nitrogen-13 ammonia imaging, and metabolism by [18F]-fluorodeoxyglucose imaging. Conclusions-Taken together, these findings establish the feasibility of molecular imaging for monitoring angiogenic gene expression with a PET reporter gene and probe noninvasively, quantitatively, and repetitively. The principles demonstrated here can be used to evaluate other therapeutic genes of interest in animal models before future clinical trials are initiated.

AB - Background-Angiogenic gene therapy is a promising treatment paradigm for patients with ischemic heart disease. In this study, we used micro-positron emission tomography (microPET) to monitor the transgene expression, function, and effects in a whole-body system. Methods and Results-Adenovirus with cytomegalovirus promoter driving an angiogenic gene (vascular endothelial growth factor [VEGF]) linked to a PET reporter gene (herpes simplex virus type 1 mutant thymidine kinase; Ad-CMV-VEGF121-CMV-HSV1-sr39tk) was used to transfect rat embryonic cardiomyoblasts in vitro. Expression of both genes correlated strongly (r=0.98; P<0.001). Afterward, rats underwent ligation of the left anterior descending artery followed by injection of 1×10 10 pfu of Ad-CMV-VEGF121-CMV-HSV1-sr39tk (study; n=35) or Ad-null (control; n=15) at the peri-infarct region. Noninvasive microPET imaging was used to assess the uptake of 9-(4-[18F]- fluorohydroxymethylbutyl)guanine ([18F]-FHBG) PET reporter probe by cells expressing the HSV1-sr39tk PET reporter gene. Cardiac transgene expression peaked at day 1 and declined over the next 2 weeks. Repeat adenoviral injections at day 60 yielded no detectable signal. The in vivo reporter gene expression (% injected dose/g of [18F]-FHBG) correlated well with ex vivo gamma counting (r=0.92), myocardial tissue HSV1-sr39TK enzyme activity (r=0.95), and myocardial tissue VEGF level (r=0.94; P<0.001 for all). The VEGF121 isoform induced significant increases in capillaries and small blood vessels. However, the level of neovasculature did not translate into significant improvements in functional parameters such as myocardial contractility by echocardiography, perfusion by nitrogen-13 ammonia imaging, and metabolism by [18F]-fluorodeoxyglucose imaging. Conclusions-Taken together, these findings establish the feasibility of molecular imaging for monitoring angiogenic gene expression with a PET reporter gene and probe noninvasively, quantitatively, and repetitively. The principles demonstrated here can be used to evaluate other therapeutic genes of interest in animal models before future clinical trials are initiated.

KW - Angiogenesis

KW - Gene therapy

KW - Imaging

KW - Myocardium

KW - Nuclear medicine

UR - http://www.scopus.com/inward/record.url?scp=4043081927&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4043081927&partnerID=8YFLogxK

U2 - 10.1161/01.CIR.0000138153.02213.22

DO - 10.1161/01.CIR.0000138153.02213.22

M3 - Article

VL - 110

SP - 685

EP - 691

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 6

ER -